1. Chung, K.F., Barnes, P.J., 1992. Role of inflammatory mediators in asthma. Br. Med. Bull. 48, 135–148.
2. Cocks, T.M., King, S.J., Angus, J.A., 1990. Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro. Br. J. Pharmacol. 100, 375–378.
3. Coleman, R.A., Smith, W.L., Narumiya, S., 1994. VIII. International Union of Pharmacology. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46, 205–229.
4. Davis, S.N., Granner, D.K., 1996. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas. In: Hardman, J.G., Goodman Gilman, A., Limbird, L.E. (Eds.), The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York, NY, pp. 1487–1517.
5. Delaey, C., Van de Voorde, J., 1995. Prostanoid-induced contractions are blocked by sulfonylureas. Eur. J. Pharmacol. 280, 179–184.